Literature DB >> 36219270

Challenges with PrEP Uptake and Adherence Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kisumu, Kenya.

Susan M Graham1, Duncan O Okall2, Supriya D Mehta3, Eve Obondi2, George Ng'ety2, Elijah Ochieng2,4, Laura Jadwin-Cakmak5, K Rivet Amico5, Gary W Harper5, Robert C Bailey2,3, Fredrick O Otieno2.   

Abstract

Data on challenges with pre-exposure prophylaxis (PrEP) uptake and adherence among Kenyan gay, bisexual, and other men who have sex with men (GBMSM) are limited. In this mixed-methods sequential explanatory design study, our quantitative phase followed 157 at-risk, HIV-negative GBMSM who accepted PrEP and enrolled in a cohort with 12-month follow-up. Stored dried blood spots collected at two intervals were batch tested for tenofovir diphosphate (TFV-DP) concentrations at study end. Despite high self-reported adherence, only 14.6% of individuals had protective TFV-DP levels at any visit. Protective TFV-DP levels were positively associated with injection drug use and a self-assessed moderate risk of acquiring HIV, and negatively associated with time since enrolment. In our subsequent qualitative phase, an intensive workshop was conducted with the GBMSM community to identify barriers and facilitators to PrEP uptake and adherence. These data revealed numerous challenges with traditional PrEP programs that must be addressed through community collaborations.
© 2022. The Author(s).

Entities:  

Keywords:  Adherence; HIV; Kenya; Men who have sex with men; Pre-exposure prophylaxis; Tenofovir disoproxil fumarate

Year:  2022        PMID: 36219270     DOI: 10.1007/s10461-022-03860-w

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  31 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.

Authors:  Sarah Masyuko; Irene Mukui; Olivia Njathi; Maureen Kimani; Patricia Oluoch; Joyce Wamicwe; Jane Mutegi; Susan Njogo; Micah Anyona; Phillip Muchiri; Lucy Maikweki; Helgar Musyoki; Prince Bahati; Jordan Kyongo; Tom Marwa; Elizabeth Irungu; Michael Kiragu; Urbanus Kioko; Justus Ogando; Dan Were; Kigen Bartilol; Martin Sirengo; Nelly Mugo; Jared M Baeten; Peter Cherutich; On Behalf Of The PrEP Technical Working Group
Journal:  Sex Health       Date:  2018-11       Impact factor: 2.706

Review 3.  Global epidemiology of HIV infection in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

Review 4.  The global response to HIV in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Chris Collins; Eugene T Richardson; Patrick S Sullivan; Jorge Sanchez; Gift Trapence; Elly Katabira; Michel Kazatchkine; Owen Ryan; Andrea L Wirtz; Kenneth H Mayer
Journal:  Lancet       Date:  2016-07-09       Impact factor: 79.321

5.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

6.  High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Authors:  Elisabeth Maria Van der Elst; Judie Mbogua; Don Operario; Gaudensia Mutua; Caroline Kuo; Peter Mugo; Jennifer Kanungi; Sagri Singh; Jessica Haberer; Frances Priddy; Eduard Joachim Sanders
Journal:  AIDS Behav       Date:  2013-07

7.  Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.

Authors:  Gaudensia Mutua; Eduard Sanders; Peter Mugo; Omu Anzala; Jessica E Haberer; David Bangsberg; Burc Barin; James F Rooney; David Mark; Paramesh Chetty; Patricia Fast; Frances H Priddy
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

8.  Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.

Authors:  Peter Mwangi Mugo; Eduard J Sanders; Gaudensia Mutua; Elisabeth van der Elst; Omu Anzala; Burc Barin; David R Bangsberg; Frances H Priddy; Jessica E Haberer
Journal:  AIDS Behav       Date:  2015-05

9.  HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Authors:  Deborah Donnell; Jared M Baeten; Namandjé N Bumpus; Justin Brantley; David R Bangsberg; Jessica E Haberer; Andrew Mujugira; Nelly Mugo; Patrick Ndase; Craig Hendrix; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

10.  "How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Kenya.

Authors:  Robinson Njoroge Karuga; Serah Nduta Njenga; Rueben Mulwa; Nduku Kilonzo; Prince Bahati; Kevin O'reilley; Lawrence Gelmon; Stephen Mbaabu; Charles Wachihi; George Githuka; Michael Kiragu
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.